GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Essex Bio-Technology Ltd (HKSE:01061) » Definitions » PB Ratio

Essex Bio-Technology (HKSE:01061) PB Ratio : 0.74 (As of May. 29, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Essex Bio-Technology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-29), Essex Bio-Technology's share price is HK$2.51. Essex Bio-Technology's Book Value per Share for the quarter that ended in Dec. 2023 was HK$3.39. Hence, Essex Bio-Technology's PB Ratio of today is 0.74.

The historical rank and industry rank for Essex Bio-Technology's PB Ratio or its related term are showing as below:

HKSE:01061' s PB Ratio Range Over the Past 10 Years
Min: 0.59   Med: 3.82   Max: 8.79
Current: 0.74

During the past 13 years, Essex Bio-Technology's highest PB Ratio was 8.79. The lowest was 0.59. And the median was 3.82.

HKSE:01061's PB Ratio is ranked better than
88% of 958 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs HKSE:01061: 0.74

During the past 12 months, Essex Bio-Technology's average Book Value Per Share Growth Rate was 11.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 11.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 15.60% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 23.30% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Essex Bio-Technology was 59.60% per year. The lowest was -11.70% per year. And the median was 23.20% per year.

Back to Basics: PB Ratio


Essex Bio-Technology PB Ratio Historical Data

The historical data trend for Essex Bio-Technology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Essex Bio-Technology PB Ratio Chart

Essex Bio-Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.04 1.66 1.64 1.39 0.73

Essex Bio-Technology Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.64 1.28 1.39 1.13 0.73

Competitive Comparison of Essex Bio-Technology's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Essex Bio-Technology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Essex Bio-Technology's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Essex Bio-Technology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Essex Bio-Technology's PB Ratio falls into.



Essex Bio-Technology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Essex Bio-Technology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=2.51/3.389
=0.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Essex Bio-Technology  (HKSE:01061) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Essex Bio-Technology PB Ratio Related Terms

Thank you for viewing the detailed overview of Essex Bio-Technology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Essex Bio-Technology (HKSE:01061) Business Description

Traded in Other Exchanges
N/A
Address
No. 88, Keji 6th Road, Hi-Tech Zone, Guangdong, Zhuhai, CHN
Essex Bio-Technology Ltd is principally engaged in investment holding and development, manufacture and sale of biologic drugs in the People's Republic of China. The company is made up of segments of Ophthalmology products and Surgical products. Its products under Ophthalmology include the Beifushu series, Tobramycin Eye Drops, Levofloxacin Eye Drops, Sodium Hyaluronate Eye Drops. The products under Surgical include the Beifuji series, Carisolv dental caries removal gel and mouth wash. The majority of the groups revenue comes from PRC.
Executives
Lauw Hui Kian
Ngiam Mia Je Patrick
Ngiam Mia Kiat Benjamin 2101 Beneficial owner

Essex Bio-Technology (HKSE:01061) Headlines

No Headlines